Picture representing current thematic area

Quarterly Summaries

The quarterly summaries provide information on Suspected Adverse Events to veterinary medicines which have been reported to the VMD.

The summaries are for the following periods:

  • Quarter 1: 1 January - 31 March
  • Quarter 2: 1 April - 30 June
  • Quarter 3: 1 July - 30 September
  • Quarter 4: 1 October - 31 December

The information is presented in four tables:

  • Animal Species Reports - this table represents the breakdown per species of all adverse event reports we have received during each quarter.
  • Serious Animal Reports - this table shows the breakdown per species of all serious adverse events received. It looks at all the serious adverse events we received and shows how many were reported to each species.
  • Non-Serious Animal Reports - this table shows the breakdown per species of non-serious adverse events received.
  • Animal Reports by Product Type - this table represents the breakdown by product type of all adverse event reports we have received during each quarter.

Please note that due to rounding the totals may not add up to 100%.


Select a year:

2014

Animal Species Report:

  Q1 Q2 Q3 Q4
Dog 56.5% 50.6% - -
Cat 26.2% 29.4% - -
Cattle 4.3% 7.2% - -
Rabbit 0.8% 2.3% - -
Horse 4.8% 5.1% - -
Sheep 2.9% 2.4% - -
Others 2.0% 2.9% - -

Serious Report:

  Q1 Q2 Q3 Q4
Dog 45.6% 46.6% - -
Cat 24.5% 28.5% - -
Cattle 11.3% 11.8% - -
Rabbit 1.4% 3.2% - -
Horse 3.6% 1.9% - -
Sheep 8.5% 3.6% - -
Others 5.2% 4.3% - -

Non-Serious Report:

  Q1 Q2 Q3 Q4
Dog 61.6% 56.8% - -
Cat 30.7% 30.7% - -
Cattle 1.1% 0.2% - -
Rabbit 0.5% 0.8% - -
Horse 5.3% 10.0% - -
Sheep 0.3% 0.6% - -
Others 0.5% 0.8% - -

Animal Report by Product Type:

  Q1 Q2 Q3 Q4
Inactivated vaccine 12.8% 13.0% - -
Live vaccine 14.6% 17.0% - -
Pain and inflammation 13.5% 12.1% - -
Skin parasites 6.1% 12.8% - -
Inactivated and live vaccine 7.7% 7.0% - -
Bacterial infections 6.2% 4.2% - -
Hormone therapy product 6.1% 8.2% - -
Miscellaneous 4.2% 3.9% - -
Internal parasites 5.0% 6.3% - -
Internal and skin parasites 7.1% 8.1% - -
Anaesthetics, sedatives and pain killers 13.2% 3.6% - -
Heart disease 2.6% 2.1% - -
Gastro-intestinal problems 0.4% 0.5% - -
Fungal infections 0.2% 0.4% - -
Coccidial infections - - - -
Dietary supplements 0.2% 0.1% - -
Anti Obesity - - - -
Protozoal infections - 0.3% - -
Respiratory problems 0.1% - - -
Immune system product - - - -
Topical infections - - - -
Anti Neoplastic Agent - 0.1% - -

2013

Animal Species Report:

  Q1 Q2 Q3 Q4
Dog 52.4% 52.7% 54.4% 56.9%
Cat 26.2% 24.9% 29.0% 28.0%
Cattle 6.8% 10.2% 6.1% 4.9%
Rabbit 2.0% 2.1% 2.5% 2.2%
Horse 7.1% 5.8% 3.5% 5.0%
Sheep 3.2% 1.8% 2.1% 1.2%
Others 2.4% 2.5% 2.4% 1.8%

Serious Report:

  Q1 Q2 Q3 Q4
Dog 39.7% 38.44% 40.9% 42.4%
Cat 23.0% 20.99% 31.9% 30.0%
Cattle 16.3% 24.76% 13.4% 13.8%
Rabbit 4.7% 3.54% 4.3% 4.2%
Horse 2.7% 2.59% 1.6% 2.5%
Sheep 8.3% 4.72% 3.9% 2.7%
Others 5.3% 5.0% 4.1% 4.4%

Non-Serious Report:

  Q1 Q2 Q3 Q4
Dog 58.8% 61.08% 64.0% 63.5%
Cat 27.9% 27.15% 26.9% 27.1%
Cattle 1.9% 1.66% 0.9% 0.8%
Rabbit 0.7% 1.25% 1.3% 1.2%
Horse 9.4% 7.62% 4.9% 6.2%
Sheep 0.5% 0.14% 0.9% 0.6%
Others 0.9% 1.1% 1.2% 0.6%

Animal Report by Product Type:

  Q1 Q2 Q3 Q4
Inactivated vaccine 12.4% 12.8% 9.6% 11.2%
Live vaccine 17.5% 13.4% 16.5% 17.8%
Pain and inflammation 13.9% 12.7% 10.4% 12.2%
Skin parasites 7.8% 9.5% 13.9% 7.9%
Inactivated and live vaccine 10.1% 9.5% 9.4% 8.0%
Bacterial infections 7.5% 5.8% 5.6% 4.5%
Hormone therapy product 6.9% 0.7% 4.8% 7.7%
Miscellaneous 3.8% 4.4% 4.5% 2.9%
Internal parasites 5.4% 5.4% 4.0% 3.8%
Internal and skin parasites 7.9% 9.5% 4.7% 6.5%
Anaesthetics, sedatives and pain killers 3.3% 9.2% 12.8% 13.4%
Heart disease 1.9% 2.3% 2.6% 3.3%
Gastro-intestinal problems 0.3% 0.4% 0.6% 0.2%
Fungal infections 0.3% 0.3% 0.2% 0.4%
Coccidial infections - 0.1% 0.1% -
Dietary supplements 0.5% - 0.2% 0.1%
Anti Obesity 0.1% 0.1% - -
Protozoal infections 0.1% - 0.1% -
Respiratory problems - 0.2% - -
Immune system product 0.2% - - -
Topical infections - - - -
Anti Neoplastic Agent - - - -

2012

Animal Species Report:

  Q1 Q2 Q3 Q4
Dog 52.9% 44.7% 46.6% 52.4%
Cat 27.5% 24.3% 29.1% 26.2%
Cattle 8.4% 15.4% 10.0% 6.8%
Rabbit 1.9% 4.1% 5.2% 2.0%
Horse 3.2% 5.4% 3.7% 7.1%
Sheep 3.4% 3.2% 2.5% 3.2%
Others 2.7% 2.9% 3.0% 2.4%

Serious Report:

  Q1 Q2 Q3 Q4
Dog 33.9% 24.7% 28.7% 39.7%
Cat 24.1% 17.7% 20.7% 23.0%
Cattle 27.1% 35.5% 25.6% 16.3%
Rabbit 3.8% 6.2% 9.4% 4.7%
Horse 1.4% 2.2% 2.0% 2.7%
Sheep 9.1% 7.5% 6.0% 8.3%
Others 5.9% 6.2% 3.0% 5.3%

Non-Serious Report:

  Q1 Q2 Q3 Q4
Dog 63.8% 58.0% 57.5% 58.8%
Cat 29.4% 28.7% 34.1% 27.9%
Cattle 0.8% 2.0% 0.5% 1.9%
Rabbit 0.8% 2.7% 2.6% 0.7%
Horse 4.2% 7.5% 4.7% 9.4%
Sheep 0.2% 0.4% 0.3% 0.5%
Others 0.8% 0.7% 0.2% 0.9%

Animal Report by Product Type:

  Q1 Q2 Q3 Q4
Inactivated vaccine 12.26% 18.73% 15.1% 10.1%
Live vaccine 18.52% 15.50% 19.9% 17.5%
Pain and inflammation 12.39% 11.09% 11.1% 13.9%
Skin parasites 9.32% 10.98% 17.3% 7.8%
Inactivated and live vaccine 11.62% 10.66% 6.9% 10.1%
Bacterial infections 7.41% 6.46% 5.4% 7.5%
Hormone therapy product 6.77% 3.66% 5.3% 0.5%
Miscellaneous 4.47% 3.66% 5.2% 3.3%
Internal parasites 4.09% 3.23% 4.6% 5.4%
Internal and skin parasites 6.77% 8.29% 4.3% 7.9%
Anaesthetics, sedatives and pain killers 3.38% 3.44% 2.4% 3.3%
Heart disease 1.28% 2.26% 2.0% 1.9%
Gastro-intestinal problems 0.38% 0.65% 0.3% 0.1%
Fungal infections 0.13% 0.11% - 0.3%
Coccidial infections - - - -
Dietary supplements 0.38% 0.97% 0.1% 0.5%
Anti Obesity - - - 0.1%
Protozoal infections 0.38% - - 0.1%
Respiratory problems - - - -
Immune system product - 0.22% - -
Topical infections - 0.11% - 0.1%
Anti Neoplastic Agent - - 0.1% 0.6%

2011

Animal Species Report:

  Q1 Q2 Q3 Q4
Dog 50.1% 43.5% 45.2% 46.1%
Cat 27.4% 26.0% 28.5% 33.4%
Cattle 7.6% 12.5% 12.5% 8.5%
Rabbit 1.3% 5.4% 3.1% 3.3%
Horse 8.2% 6.7% 4.8% 3.9%
Sheep 2.9% 2.9% 3.1% 3.4%
Others 2.6% 2.9% 2.6% 1.3%

Serious Report:

  Q1 Q2 Q3 Q4
Dog 34.4% 27.2% 29.2% 35.47%
Cat 23.1% 18.5% 21.7% 23.31%
Cattle 22.2% 29.9% 29.8% 21.62%
Rabbit 1.9% 7.1% 24.7% 5.41%
Horse 1.9% 4.3% 2.2% 2.03%
Sheep 9.4% 7.5% 6.5% 9.12%
Others 7.1% 5.5% 5.9% 3.04%

Non-Serious Report:

  Q1 Q2 Q3 Q4
Dog 57.0% 52.5% 55.4% 52.1%
Cat 29.2% 30.1% 32.8% 39.1%
Cattle 1.2% 3.0% 1.6% 1.0%
Rabbit 1.0% 4.5% 2.2% 2.1%
Horse 10.9% 8.0% 6.5% 5.0%
Sheep - 0.4% 1.0% 0.2%
Others 0.6% 1.5% 0.6% 0.4%

Animal Report by Product Type:

  Q1 Q2 Q3 Q4
Inactivated vaccine 14.33% 18.22% 18.05% 14.53%
Live vaccine 14.76% 14.33% 17.69% 19.58%
Pain and inflammation 10.74% 9.46% 11.91% 10.47%
Skin parasites 5.16% 8.48% 8.90% 9.11%
Inactivated and live vaccine 16.62% 11.96% 11.19% 9.61%
Bacterial infections 8.60% 8.07% 7.58% 6.40%
Hormone therapy product 5.16% 5.29% 8.18% 6.40%
Miscellaneous 5.44% 5.01% 3.25% 4.31%
Internal parasites 4.30% 4.87% 4.81% 5.30%
Internal and skin parasites 6.45% 7.09% 3.85% 6.90%
Anaesthetics, sedatives and pain killers 5.44% 5.56% 2.89% 3.45%
Heart disease 1.15% 0.70% 0.48% 1.72%
Gastro-intestinal problems 0.72% 0.56% 0.36% 0.86%
Fungal infections 0.14% 0.14% - 0.49%
Coccidial infections - - - 0.12%
Dietary supplements 0.72% - 0.48% 0.12%
Anti Obesity - - - -
Protozoal infections - - 0.12% 0.25%
Respiratory problems - 0.28% 0.12% 0.25%
Immune system product 0.14% - 0.12% -
Topical infections 0.14% - - -

2010

Animal Species Report:

  Q1 Q2 Q3 Q4
Dog 47.0% 38.8% 44.2% 49.9%
Cat 31.4% 26.8% 29.1% 30.8%
Cattle 11.1% 19.4% 14.3% 5.8%
Rabbit 1.4% 4.9% 5.3% 2.8%
Horse 5.0% 4.3% 3.4% 6.2%
Sheep 2.4% 2.9% 2.0% 2.6%
Others 1.7% 2.8% 1.7% 1.9%

Serious Report:

  Q1 Q2 Q3 Q4
Dog 33.0% 24.9% 28.2% 37.9%
Cat 28.3% 17.2% 21.1% 27.2%
Cattle 22.7% 40.8% 35.2% 14.8%
Rabbit 2.6% 4.9% 4.9% 4.7%
Horse 2.6% 1.9% 1.8% 1.2%
Sheep 6.4% 6.5% 4.9% 8.3%
Others 4.3% 3.9% 3.9% 5.9%

Non-Serious Report:

  Q1 Q2 Q3 Q4
Dog 54.6% 49.5% 53.6% 54.5%
Cat 33.1% 34.2% 33.7% 32.1%
Cattle 4.7% 3.0% 2.1% 2.5%
Rabbit 0.7% 5.0% 5.6% 2.0%
Horse 6.4% 6.2% 4.3% 8.0%
Sheep 0.2% 0.2% 0.2% 0.4%
Others 0.2% 2.0% 0.4% 0.4%

Animal Report by Product Type:

  Q1 Q2 Q3 Q4
Inactivated vaccine 12.54% 20.20% 21.38% 15.07%
Live vaccine 15.90% 15.29% 17.08% 15.24%
Pain and inflammation 14.53% 8.70% 12.13% 9.56%
Skin parasites 4.43% 7.29% 11.73% 8.10%
Inactivated and live vaccine 10.70% 10.38% 9.26% 13.45%
Bacterial infections 6.88% 6.31% 6.13% 6.65%
Hormone therapy product 7.65% 5.75% 5.48% 6.48%
Miscellaneous 10.70% 6.17% 4.95% 4.38%
Internal parasites 2.60% 4.77% 4.04% 4.54%
Internal and skin parasites 3.82% 6.87% 3.13% 6.97%
Anaesthetics, sedatives and pain killers 6.73% 5.75% 3.00% 7.78%
Heart disease 0.61% 0.42% 0.65% 0.65%
Gastro-intestinal problems 1.38% 0.56% 0.26% 0.65%
Fungal infections 0.15% - 0.26% 0.32%
Coccidial infections - 0.28% 0.26% -
Dietary supplements 0.46% 1.12% 0.13% 0.16%
Anti Obesity 0.31% - 0.13% -
Protozoal infections - 0.14% -  
Respiratory problems 0.46% - - -
Immune system product 0.15% - - -
Topical infections - - - -

2009

Animal Species Report:

  Q1 Q2 Q3 Q4
Dog 44.0% 42.9% 47.4% 43.3%
Cat 31.9% 28.8% 33.4% 35.9%
Cattle 13.0% 15.6% 7.5% 8.1%
Rabbit 2.8% 3.6% 4.5% 4.7%
Horse 3.2% 3.0% 3.1% 2.9%
Sheep 2.5% 3.3% 1.7% 2.4%
Others 2.6% 3.0% 2.5% 2.7%

Serious Report:

  Q1 Q2 Q3 Q4
Dog 28.2% 29.2% 41.1% 29.0%
Cat 23.1% 16.0% 25.1% 30.0%
Cattle 31.8% 37.4% 17.7% 17.1%
Rabbit 3.6% 2.9% 5.2% 8.6%
Horse 1.0% 1.2% 1.3% 1.0%
Sheep 6.2% 7.8% 43.9% 6.7%
Others 6.2% 5.3% 5.6% 7.6%

Non-Serious Report:

  Q1 Q2 Q3 Q4
Dog 53.1% 51.2% 51.2% 51.2%
Cat 37.0% 36.5% 38.6% 39.1%
Cattle 2.1% 2.3% 1.1% 3.1%
Rabbit 2.4% 4.0% 4.0% 2.6%
Horse 4.5% 4.0% 4.3% 3.9%
Sheep 0.3% 0.5% 0.3% 0.0%
Others 0.6% 1.5% 0.5% 0.0%

Animal Report by Product Type:

  Q1 Q2 Q3 Q4
Inactivated vaccine 22.08% 24.26% 15.89% 12.52%
Live vaccine 12.83% 13.84% 15.40% 16.07%
Pain and inflammation 14.15% 10.26% 12.75% 10.32%
Skin parasites 5.09% 77.78% 10.93% 7.11%
Inactivated and live vaccine 10.75% 11.04% 10.10% 11.17%
Bacterial infections 7.55% 6.69% 5.46% 8.63%
Hormone therapy product 11.32% 8.24% 5.63% 8.29
Miscellaneous 2.08% 3.42% 4.80% 7.11%
Internal parasites 3.96% 4.67% 5.46% 2.71%
Internal and skin parasites 3.58% 3.89% 5.63%% 4.23%
Anaesthetics, sedatives and pain killers 3.58% 3.27% 5.30% 9.31%
Heart disease 0.57% 1.40% 0.99% 0.68%
Gastro-intestinal problems 0.75% 0.62% 0.83% 0.85%
Fungal infections 0.19% - - 0.34%
Coccidial infections 0.19% - 0.17% -
Dietary supplements 0.57% 0.31% 0.33% 0.51%
Anti Obesity 0.57% - 0.33% 0.17%
Protozoal infections - - - -
Respiratory problems 0.19% 0.16% - -
Immune system product - 0.16% - -
Topical infections - - - -


Last Updated: 23 April 2012

ISO 27001 Accredited logo Positive about disabled people logo iip logo

The VMD is an executive agency of defra defra logo